Xenetic Biosciences, Inc. Quarterly Common Stock, Shares Authorized from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Xenetic Biosciences, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2011 to Q2 2024.
  • Xenetic Biosciences, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 10M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 10M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 10M -90M -90% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 10M 0 0% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 10M -40M -80% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 10M -40M -80% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 100M +50M +100% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 10M -40M -80% Dec 31, 2022 10-K 2024-03-21
Q3 2022 50M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 50M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 50M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 50M 0 0% Dec 31, 2021 10-K 2023-03-22
Q3 2021 50M +37.5M +300% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 50M +37.5M +300% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 50M +37.5M +300% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 50M +37.5M +300% Dec 31, 2020 10-K 2022-03-22
Q3 2020 12.5M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 12.5M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 12.5M -33M -72.5% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 12.5M 0 0% Dec 31, 2019 10-K 2021-03-16
Q3 2019 12.5M -33M -72.5% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 12.5M -33M -72.5% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 45.5M 0 0% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 12.5M -33M -72.5% Dec 31, 2018 10-K 2020-03-26
Q3 2018 45.5M 0 0% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 45.5M 0 0% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 45.5M 0 0% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 45.5M 0 0% Dec 31, 2017 10-K 2019-03-29
Q3 2017 45.5M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 45.5M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 45.5M -1.45B -97% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 45.5M 0 0% Dec 31, 2016 10-K 2018-03-30
Q3 2016 45.5M -1.45B -97% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 45.5M -170M -78.9% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 1.5B +1.28B +596% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 45.5M -170M -78.9% Dec 31, 2015 10-K 2017-03-31
Q3 2015 1.5B +1.28B +596% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 215M 0 0% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 215M 0 0% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 215M 0 0% Dec 31, 2014 10-K 2016-03-30
Q3 2014 215M -84.5M -28.2% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 215M -84.5M -28.2% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 215M -84.5M -28.2% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 215M 0 0% Dec 31, 2013 10-K/A 2015-07-20
Q3 2013 300M 0 0% Aug 31, 2013 10-Q 2014-01-10
Q2 2013 300M +210M +233% May 31, 2013 10-Q 2013-07-17
Q1 2013 300M Feb 28, 2013 10-Q 2013-04-22
Q4 2012 215M Dec 31, 2012 10-K/A 2015-07-20
Q3 2012 300M +210M +233% Aug 31, 2012 10-K 2013-11-27
Q2 2012 90M May 31, 2012 10-Q 2012-07-16
Q3 2011 90M Aug 31, 2011 10-K 2012-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.